RELATIONSHIP BETWEEN EXPRESSION OF SYNOVIAL B CELL SURVIVAL FACTORS AND CLINICAL RESPONSE TO RITUXIMAB TREATMENT IN RHEUMATOID ARTHRITIS

被引：0
|
作者：
Thurlings, R. [1 ]
Boumans, M. [1 ]
de Jager, W. [2 ]
Vos, K. [1 ,3 ]
van Baarsen, L. [1 ]
Gerlag, D. [1 ]
Prakken, B. [2 ]
Tak, P. P. [1 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Med Ctr Utrecht, Utrecht, Netherlands
[3] Flevoziekenhuis, Almere, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.5312
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0140
引用
收藏
页码：850 / 850
页数：1
相关论文
共 50 条
  • [1] RELATIONSHIP BETWEEN EXPRESSION OF SYNOVIAL B CELL SURVIVAL FACTORS AND CLINICAL RESPONSE TO RITUXIMAB TREATMENT IN RHEUMATOID ARTHRITIS
    Thurlings, Rogier M.
    Boumans, Marie
    de Jager, W. J.
    Vos, Koen
    van Westing, Daisy Marie
    van Baarsen, Lisa G.
    Gerlag, Danielle M.
    Prakken, B.
    Tak, Paul P.
    Tak, Paul P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : A32 - A32
  • [2] Relationship between clinical response, rituximab pharmacokinetics and peripheral B cell levels in rheumatoid arthritis
    Breedveld, F. C.
    Agarwal, S.
    Yin, M.
    Ng, C.
    Li, N. F.
    Shaw, T. M.
    Davies, B. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 179 - 179
  • [3] Relationship between clinical response, rituximab pharmacokinetics, and peripheral B cell levels in rheumatoid arthritis.
    Breedveld, FC
    Agarwal, S
    Yin, M
    Ng, C
    Li, NF
    Sewell, KL
    Shaw, TM
    Davies, BE
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S138 - S138
  • [4] Relationship between clinical response, rituximab (RTX) pharmacokinetics, and peripheral B cell levels in rheumatoid arthritis (RA).
    Breedveld, F.
    Agarwal, S.
    Yin, M.
    Ng, C.
    Li, N.
    Shaw, T.
    Davies, B.
    [J]. CLINICAL IMMUNOLOGY, 2006, 119 : S64 - S65
  • [5] Synovial B-cell proportions and treatment response in rheumatoid arthritis
    Clark, Anna
    [J]. LANCET RHEUMATOLOGY, 2020, 2 (01): : E12 - E12
  • [6] Synovial tissue response to rituximab in rheumatoid arthritis
    Tak, Paul P.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (02) : 184 - 184
  • [7] B Cell Activation Biomarkers as Predictive Factors for the Response to Rituximab in Rheumatoid Arthritis
    Sellam, Jeremie
    Hendel-Chavez, Houria
    Rouanet, Stephanie
    Abbed, Karim
    Combe, Bernard
    Le Loet, Xavier
    Tebib, Jacques
    Sibilia, Jean
    Taoufik, Yassine
    Dougados, Maxime
    Mariette, Xavier
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (04): : 933 - 938
  • [8] Associations Between Rheumatoid Arthritis Clinical Factors and Synovial Cell Types and States
    Weisenfeld, Dana
    Zhang, Fan
    Donlin, Laura
    Jonsson, Anna Helena
    Apruzzese, William
    Campbell, Debbie
    Rao, Deepak A.
    Wei, Kevin
    Holers, V. Michael
    Gravallese, Ellen
    Moreland, Larry
    Goodman, Susan
    Brenner, Michael
    Raychaudhuri, Soumya
    Filer, Andrew
    Anolik, Jennifer
    Bykerk, Vivian
    Liao, Katherine P.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2024, 76 (03) : 356 - 362
  • [9] STATINS DO NOT INFLUENCE CLINICAL RESPONSE AND B CELL DEPLETION AFTER RITUXIMAB TREATMENT IN RHEUMATOID ARTHRITIS
    Das, S.
    Matilla, M. Fernandez
    Dass, S.
    Vital, E.
    Emery, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 196 - 196
  • [10] Statins do not influence clinical response and B cell depletion after rituximab treatment in rheumatoid arthritis
    Das, Sudipto
    Matilla, Meritxell Fernandez
    Dass, Shouvik
    Buch, Maya H.
    Rawstron, Andrew C.
    Vital, Edward M.
    Emery, Paul
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (03) : 463 - 464
12345